Ampio Pharmaceuticals Depreciation & Amortization 2011-2026 | AMPE

Annual Depreciation & Amortization Ampio Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
122 K	1.05 M	1.09 M	1.18 M	1.27 M	1.28 M	1.21 M	1.21 M	825 K	341 K	138 K	62.4 K	42.6 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.28 M	42.6 K	756 K

Quarterly Depreciation & Amortization Ampio Pharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	122 K	-	347 K	256 K	262 K	-	831 K	568 K	294 K	-	885 K	591 K	295 K	-	975 K	736 K	365 K	-	968 K	621 K	301 K	-	911 K	607 K	304 K	-	917 K	611 K	306 K	-	618 K	412 K	206 K	-	210 K	83.1 K	41.2 K	-	97.3 K	57.8 K	18.5 K	-	46.8 K	31.2 K	15.6 K	-	27 K	11.4 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
975 K	11.4 K	387 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Altimmune ALT	112 K	$ 3.41	2.1 %	$ 300 M	USA
Amgen AMGN	5.17 B	$ 350.17	0.68 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.57	0.36 %	$ 915 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	7.55 M	$ 1.4	1.82 %	$ 357 M	Britain
Aytu BioScience AYTU	5.38 M	$ 2.64	1.15 %	$ 16.6 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Benitec Biopharma BNTC	66 K	$ 11.0	0.18 %	$ 453 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.58	3.62 %	$ 185 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	311 K	$ 12.83	0.71 %	$ 773 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
CorMedix CRMD	677 K	$ 6.29	0.64 %	$ 453 K	USA
CytomX Therapeutics CTMX	1.2 M	$ 4.41	-1.01 %	$ 608 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Compugen Ltd. CGEN	461 K	$ 2.12	1.2 %	$ 198 M	Israel
Denali Therapeutics DNLI	7.8 M	$ 20.92	3.69 %	$ 3.44 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.26	0.47 %	$ 707 M	Canada
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA